Prediction Case File
YouTubeEvaluation Complete

Ouster Stock Analysis! 20x or Hype?

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
14 May 2026, 17:24 UTC
Recorded by Tahlil Plus
19 May 2026, 02:53 UTC
Video preview for Ouster Stock Analysis! 20x or Hype?
Source overview

AI-generated source summary

The analysis focuses on Ouster Inc. (OUST), a company in the lidar sensor and robotics sector. The stock is currently trading at $34.17, showing a year-to-date gain of 46.21%. The company is identified as a leader in providing sensors for autonomous vehicles, industrial automation, and robotics. Ouster's financial performance is highlighted, with a significant increase in gross margin to 43% and revenue growth of 49% year-over-year, despite a 22% sequential decline in revenue. The company's forward price-to-sales ratio is noted to be around 8.5x, which is considered reasonable given its growth potential and the fact that it is not yet profitable. The analysis also touches upon geopolitical risks related to Chinese competition and US government regulations, but the overall sentiment remains positive due to Ouster's technological advancements and market position, particularly in humanoids and smart infrastructure. The forward-looking guidance suggests continued revenue growth and eventual profitability.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  7. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.5
Tracked signals
359
Historical success
34.3%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail